Revolutionize Your Cell Line Development Workflows
This white paper focuses on technologies used for developing clones for cell line development and demonstrates how to shorten the timeline from 2 to 3 months down to 1 month. It includes a discussion on current limitations and how to address them, including proof of clonality and inefficient workflows.
Key Highlights
- The demand for accelerated and audit-ready cell line development remains unmet in the biopharma community.
- Demonstrating clonality is crucial to ensure genomic homogeneity, consistent manufacturing, and safety of products.
- Single cell cloning using CellRaftA microscale polystyrene growth surface within an array used to spatially segregate cells/colonies while maintaining shared media access, enabling imaging over time and targeted isolation. More Technology provides seamless cloning and images for proof of monoclonalityEvidence that a colony/line originated from one cell; often supported by time-course imaging and traceability. More.
- Traditional multimode platforms used in cell line development lead to increased costs and operational inefficiency, while CellRaftA microscale polystyrene growth surface within an array used to spatially segregate cells/colonies while maintaining shared media access, enabling imaging over time and targeted isolation. More Technology aims to reduce time and increase efficiency and success rates.
Download the White Paper
[glossary]
[/glossary]
Contact Us
Cell Microsystems
801 Capitola Drive, Ste 10
Durham, NC 27713
252.285.9842
Follow Us
© 2026 Cell Microsystems. All rights reserved.
Privacy Statement, Cookie Policy and Disclaimers.